Zamagni, E., Dhakal, B., Iida, S., Sidiqi, M., Yoon, S., Callander, N., Touzeau, C., Li, Q., Balogh, A., Slaughter, A., Benachour, N., Lonardi, C., Ghosh, A., Vogel, M., Lendvai, N., Lengil, T., Koneru, M., Patel, N., Costa Filho, O., Mahajan, V., Martínez-López, J., Yong, K., Weisel, K. and Leleu, X. (2026) “P36 | EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14045.